Can pre-emptive germline testing and genomics help resolve challenges in cervical cancer?
Evidence from across the world suggests around 10% of patients with cancer have a germline or hereditary genetic variant, which make them predisposed to developing cancer. Understanding the gene and variant could have implications in screening additional members in the family. Know more